{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:44:24Z","timestamp":1762004664865},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.diabres.2015.01.018","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T20:48:51Z","timestamp":1421873331000},"page":"332-337","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Time to and factors associated with insulin initiation in patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"107","author":[{"given":"Jorge Enrique","family":"Machado-Alba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Enrique","family":"Machado-Duque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Andrea","family":"Moreno-Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.diabres.2015.01.018_bib0160","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1590\/S1020-49892010001200008","article-title":"Treatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries. Latin American Diabetes Association","volume":"28","author":"Guzman","year":"2010","journal-title":"Rev Panam Salud Publica"},{"issue":"2","key":"10.1016\/j.diabres.2015.01.018_bib0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence in adults for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2015.01.018_bib0170","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: principles of pathogenesis and therapy","volume":"365","author":"Stumvoll","year":"2005","journal-title":"Lancet"},{"issue":"9786","key":"10.1016\/j.diabres.2015.01.018_bib0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","article-title":"Management of type 2 diabetes: new and future developments in treatment","volume":"378","author":"Tahrani","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.diabres.2015.01.018_bib0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00003495-200565030-00005","article-title":"Oral antidiabetic agents: current role in type 2 diabetes mellitus","volume":"65","author":"Krentz","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.diabres.2015.01.018_bib0185","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.diabres.2015.01.018_bib0190","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.hlc.2010.07.013","article-title":"Intensive glucose control and cardiovascular outcomes in type 2 diabetes","volume":"20","author":"Macisaac","year":"2011","journal-title":"Heart Lung Circ"},{"issue":"15","key":"10.1016\/j.diabres.2015.01.018_bib0195","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"9 Suppl. 1","key":"10.1016\/j.diabres.2015.01.018_bib0200","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.amjmed.2013.06.011","article-title":"Intensifying insulin therapy: what options are available to patients with type 2 diabetes?","volume":"126","author":"Meneghini","year":"2013","journal-title":"Am J Med"},{"issue":"9 Suppl. 1","key":"10.1016\/j.diabres.2015.01.018_bib0205","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2013.06.010","article-title":"Initiating basal insulin therapy in type 2 diabetes: practical steps to optimize glycemic control","volume":"126","author":"Philis-Tsimikas","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.diabres.2015.01.018_bib0210","doi-asserted-by":"crossref","first-page":"1249e58","DOI":"10.2337\/diab.44.11.1249","article-title":"UKPDS 16. Overview of 6 years of therapy in type 2 diabetes: a progressive disease","volume":"44","author":"UK Prospective Diabetes Study Group","year":"1995","journal-title":"Diabetes"},{"issue":"Suppl. 3","key":"10.1016\/j.diabres.2015.01.018_bib0215","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/sj.ijo.0802173","article-title":"When oral agents fail: practical barriers to starting insulin","volume":"26","author":"Korytkowski","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"11","key":"10.1016\/j.diabres.2015.01.018_bib0220","first-page":"801","article-title":"Initiation of insulin for type 2 diabetes mellitus patients: what are the issues? A qualitative study","volume":"52","author":"Tan","year":"2011","journal-title":"Singapore Med J"},{"issue":"Suppl. 3A","key":"10.1016\/j.diabres.2015.01.018_bib0225","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.amjmed.2003.12.003","article-title":"Timely initiation of basal insulin","volume":"116","author":"Riddle","year":"2004","journal-title":"Am J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2015.01.018_bib0230","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S1751-9918(10)60008-3","article-title":"Practical guidance to insulin management","volume":"4","author":"Meneghini","year":"2010","journal-title":"Prim Care Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2015.01.018_bib0235","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3810\/pgm.2014.05.2767","article-title":"Understanding the type 2 diabetes mellitus and cardiovascular disease risk paradox","volume":"126","author":"Green","year":"2014","journal-title":"Postgrad Med"},{"issue":"2","key":"10.1016\/j.diabres.2015.01.018_bib0240","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.pharmthera.2009.11.001","article-title":"Glycaemic control in type 2 diabetes: targets and new therapies","volume":"125","author":"Tahrani","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.diabres.2015.01.018_bib0245","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.diabres.2014.01.004","article-title":"Call-to-action: timely and appropriate treatment for people with type 2 diabetes in Latin America","volume":"104","author":"Escalante","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.diabres.2015.01.018_bib0250","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.diabres.2013.11.010","article-title":"Diabetes in South and Central America: an update","volume":"103","author":"Aschner","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.diabres.2015.01.018_bib0255","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-150-6-200903170-00008","article-title":"Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement","volume":"150","author":"US Preventive Services Task Force","year":"2009","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.diabres.2015.01.018_bib0260","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.diabet.2009.11.006","article-title":"Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes","volume":"36","author":"Ringborg","year":"2010","journal-title":"Diabetes Metab"},{"issue":"7","key":"10.1016\/j.diabres.2015.01.018_bib0265","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5694\/j.1326-5377.2006.tb00264.x","article-title":"Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes Study","volume":"184","author":"Davis","year":"2006","journal-title":"Med J Aust"},{"issue":"6","key":"10.1016\/j.diabres.2015.01.018_bib0270","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1590\/S1020-49892009001200008","article-title":"Quality and effectiveness of diabetes care for a group of patients in Colombia","volume":"26","author":"Machado-Alba","year":"2009","journal-title":"Rev Panam Salud Publica"},{"issue":"11","key":"10.1016\/j.diabres.2015.01.018_bib0275","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.2337\/dc13-0331","article-title":"Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people","volume":"36","author":"Khunti","year":"2013","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.diabres.2015.01.018_bib0280","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1464-5491.2002.00743.x","article-title":"Changes in treatment after the start of oral hypoglycaemic therapy in Type 2 diabetes: a population-based study","volume":"19","author":"Donnan","year":"2002","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.diabres.2015.01.018_bib0285","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11606-007-0139-y","article-title":"Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy","volume":"22","author":"Nichols","year":"2007","journal-title":"J Gen Intern Med"},{"issue":"10","key":"10.1016\/j.diabres.2015.01.018_bib0290","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/aje\/kwt177","article-title":"All-cause, cardiovascular, and cancer mortality rates in postmenopausal white, black, Hispanic, and Asian women with and without diabetes in the United States: the Women's Health Initiative, 1993\u20132009","volume":"178","author":"Ma","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.diabres.2015.01.018_bib0295","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s13300-012-0012-9","article-title":"Initial sulfonylurea use and subsequent insulin therapy in older subjects with type 2 diabetes mellitus","volume":"3","author":"Fu","year":"2012","journal-title":"Diabetes Ther"},{"issue":"6","key":"10.1016\/j.diabres.2015.01.018_bib0300","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1592\/phco.2005.25.6.810","article-title":"Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus","volume":"25","author":"Eurich","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.diabres.2015.01.018_bib0305","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/157339910791658844","article-title":"Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review","volume":"6","author":"Carella","year":"2010","journal-title":"Curr Diabetes Rev"},{"issue":"6","key":"10.1016\/j.diabres.2015.01.018_bib0310","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2014.02.014","article-title":"Statin treatment and new-onset diabetes: a review of proposed mechanisms","volume":"63","author":"Brault","year":"2014","journal-title":"Metabolism"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822715000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822715000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T05:49:31Z","timestamp":1598680171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822715000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0168822715000261"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2015.01.018","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time to and factors associated with insulin initiation in patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2015.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}